System1 Biosciences

System1 Biosciences is a privately held company based in San Francisco, California. With a team of 13 employees, the company focuses on the development of neurotherapeutics. System1 Biosciences utilizes AI-driven phenotypic screening to discover and develop new drugs for complex brain diseases. Their approach focuses on identifying novel therapeutic targets and treatments by characterizing the etiology and expression of disease at molecular, cellular, and tissue levels. The company leverages robotic automation and machine learning to industrialize complex in vitro experimental science, enabling them to explore disease mechanisms in depth. This "deep phenotype" analysis allows for the identification of new drug candidates that may have been missed by traditional discovery techniques. For more information about System1 Biosciences and their innovative neurotherapeutics, visit their website at system1.bio.